GlassScriptPhysician profile
Padma Horvit
NPI 1215949169
$18,777.74
in general payments reported to CMS, 2019-2025
55 companies · $2,691 in 2025
The $2,691 reported for 2025 was more than what 81% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,587 · 2020: $2,732 · 2021: $2,596 · 2022: $2,797 · 2023: $2,746 · 2024: $2,629 · 2025: $2,691.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,980 · Education: $85.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,979.75 |
| Education | $85.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $3,711.83 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $2,031.45 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $1,393.62 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,321.50 | 2019-2024 | Farxiga, Lokelma |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,231.25 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Bayer Healthcare Pharmaceuticals INC. | $1,076.45 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $821.44 | 2019-2024 | |
| Abbott Laboratories | $651.49 | 2019-2025 | Freestyle Libre 3 |
| Ibsa Pharma INC. | $647.93 | 2019-2025 | Tirosint, Licart, Licart |
| Xeris Pharmaceuticals, INC. | $573.42 | 2021-2025 | Gvoke Hypopen, Recorlev |
| Amneal Pharmaceuticals LLC | $568.61 | 2019-2025 | Unithroid |
| Mannkind Corporation | $466.06 | 2019-2023 | Afrezza |
| Tandem Diabetes Care, INC. | $365.82 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Amarin Pharma, INC. | $360.27 | 2019-2022 | |
| Radius Health, INC. | $350.38 | 2019-2025 | Tymlos |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $305.30 | 2020-2025 | Dexcom G6 Transmitter |
| Amgen INC. | $285.24 | 2019-2025 | Tepezza, Evenity, Prolia |
| Corcept Therapeutics | $266.45 | 2020-2025 | Korlym |
| Insulet Corporation | $212.41 | 2019-2025 | Omnipod |
| Merck Sharp & Dohme LLC | $211.01 | 2019-2022 | |
| Medtronic, INC. | $194.56 | 2021-2025 | Minimed 780g |
| Cequr Corporation | $161.49 | 2022-2024 | Cequr Simplicity |
| Janssen Pharmaceuticals, INC | $150.59 | 2019-2020 | |
| Lifescan, INC. | $112.77 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $91.16 | 2019-2022 | |
| Recordati_rare_diseases_inc. | $83.90 | 2025 | Isturisa, Signifor Lar |
| Medtronic Minimed, INC. | $83.64 | 2019-2020 | |
| Averitas Pharma INC. | $79.63 | 2024-2025 | Qutenza |
| Alvogen INC | $76.35 | 2023-2025 | Teriparatide |
| Ascend Therapeutics US, LLC | $64.92 | 2020-2021 | |
| Valeritas, INC. | $61.68 | 2019 | |
| Alexion Pharmaceuticals, INC. | $59.84 | 2019-2023 | |
| Acerus Pharmaceuticals Corporation | $56.62 | 2020-2021 | |
| Sequel Med Tech, LLC | $54.21 | 2025 | Twiist |
| Novartis Pharmaceuticals Corporation | $51.30 | 2023 | |
| Antares Pharma, INC. | $49.64 | 2022-2023 | Tlando, Nocdurna, Xyosted |
| Althera Pharmaceuticals LLC | $48.49 | 2021 | |
| Shire North American Group INC | $41.37 | 2019 | |
| Intuity Medical INC | $37.05 | 2022-2023 | Pogo Automatic Blood Glucose Monitoring System |
| Ascendis Pharma Endocrinology INC | $35.25 | 2025 | Yorvipath |
| Becton, Dickinson and Company | $33.68 | 2021-2022 | |
| Beta Bionics, INC. | $31.19 | 2024 | Ilet Bionic Pancreas |
| Acella Pharmaceuticals, LLC | $30.00 | 2025 | NP Thyroid 60 |
| Ultragenyx Pharmaceutical INC. | $28.65 | 2021 | |
| Amryt Pharma Holdings LTD | $26.72 | 2022 | |
| Horizon Therapeutics Plc | $25.68 | 2022 | |
| Neurocrine Biosciences, INC. | $24.11 | 2025 | |
| Glaxosmithkline, LLC. | $24.03 | 2025 | Shingrix |
| Rgh Enterprises LLC | $24.02 | 2025 | |
| Rhythm Pharmaceuticals, INC. | $17.31 | 2025 | Imcivree |
| Bigfoot Biomedical INC | $16.01 | 2022 | |
| Clarus Therapeutics INC. | $15.00 | 2021 | |
| Arbor Pharmaceuticals, INC. | $12.16 | 2020 | |
| Aytu Biopharma, INC. | $11.61 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $11.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Padma Horvit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.